
1:2 stock split: THIS company fixes record date, check details here
शेयर बाजार में हाहाकार, अरबों डॉलर हुए स्वाहा
MURAE Organisor Ltd has officially announced a stock split in the ratio of 1:2, marking yet another strategic step in its effort to broaden investor participation and increase stock liquidity. The company's Board of Directors has fixed Wednesday, June 11, 2025, as the record date for this sub-division of equity shares. Shareholders holding one equity share of face value ₹2 as of the record date will receive two equity shares of ₹1 each. This move, approved by shareholders through a postal ballot on May 29, 2025, is expected to lower the entry barrier for retail investors while improving market depth.
Earlier, the company had announced its intent to acquire agricultural land in the strategically vital region of Kutch, Gujarat. This acquisition underscores the company's commitment to broadening its business horizons into agriculture and industrial sectors.
The proposed acquisition involves an investment estimated between INR 200 million and INR 250 million. This initiative is contingent upon thorough due diligence processes and the requisite regulatory approvals and statutory clearances.
The company intends to utilize the acquired land primarily for cultivating premium-quality pomegranates, exploiting Kutch's advantageous agro-climatic conditions, renowned for high-yield and quality horticulture. This agricultural project aligns seamlessly with government schemes aimed at promoting modern agricultural practices and sustainable growth, including the National Horticulture Mission and Pradhan Mantri Krishi Sinchai Yojana (PMKSY).
Additionally, MURAE Organisor Ltd. plans to set up a state-of-the-art distillery facility on the acquired premises, significantly broadening its operational capacity and enhancing its product offerings. This diversification into value-added products in the industrial segment positions the company strategically in an under-explored yet lucrative market segment, promising substantial margin improvement and sustainable long-term growth.
The company's proposed venture is poised to benefit significantly from the Gujarat Industrial Policy 2020, which offers various incentives such as capital subsidies, tax concessions, and infrastructure support. The supportive regulatory environment, coupled with sector-specific government initiatives, creates an encouraging framework for rapid and profitable business expansion.
For the financial year ended March 31, 2025, the company reported total revenue of ₹85.48 crore, a staggering increase compared to just ₹0.25 crore in FY24. The full-year net profit stood at ₹7.51 crore, against ₹5.31 lakh in the previous year, signaling a strong earnings rebound. The Q4FY25 net profit alone was ₹2.85 crore, underscoring consistent quarterly performance. MURAE's financials also show a notable build-up in trade receivables and cash positions, suggesting an expansion in operational scale and reach.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Print
an hour ago
- The Print
Murae Organisor board approves share split, to invest around Rs 25 cr in agri venture
New Delhi, Jun 2 (PTI) Pharmaceutical distributor Murae Organisor on Monday said its board has approved a 1:2 stock split with June 11 as the record date and also plans to invest around Rs 25 crore in an agri venture. The company's board has fixed June 11 as the record date for the division of every share into two shares, Ahmedabad-based Murae Organisor Ltd said in a release.


Economic Times
10 hours ago
- Economic Times
Murae Organisor board approves share split, to invest around Rs 25 crore in agri venture
Murae Organisor stock split Pharmaceutical distributor Murae Organisor on Monday said its board has approved a 1:2 stock split with June 11 as the record date and also plans to invest around Rs 25 crore in an agri venture. The company's board has fixed June 11 as the record date for the division of every share into two shares, Ahmedabad-based Murae Organisor Ltd said in a release. The company is also strategically expanding into the agro-industrial sector with an investment of Rs 20-25 crore to acquire agricultural land in Kutch, Gujarat, for the cultivation of high-quality pomegranates. It will also set up a distillery facility in Kutch, the company Organisor has posted a multi-fold jump in revenue to Rs 854.82 crore for 2024-25 compared to revenue of Rs 2.54 crore in FY 2024. Net profit for FY 2025 surged to Rs 7.52 crore against Rs 5.31 lakh in FY 2024.. The company is engaged in the pharmaceutical business, including the marketing, trading, and distribution of a range of pharmaceutical products, such as antibiotics, anti-malarial drugs, and anti-allergic medications.


Time of India
10 hours ago
- Time of India
Murae Organisor board approves share split, to invest around Rs 25 crore in agri venture
Murae Organisor's board has approved a 1:2 stock split, setting June 11 as the record date. The company is strategically diversifying into the agro-industrial sector with a Rs 20-25 crore investment in Kutch, Gujarat, for pomegranate cultivation and a distillery. The company experienced a significant surge in revenue and net profit for FY 2025. Tired of too many ads? Remove Ads Pharmaceutical distributor Murae Organisor on Monday said its board has approved a 1:2 stock split with June 11 as the record date and also plans to invest around Rs 25 crore in an agri company's board has fixed June 11 as the record date for the division of every share into two shares, Ahmedabad-based Murae Organisor Ltd said in a company is also strategically expanding into the agro-industrial sector with an investment of Rs 20-25 crore to acquire agricultural land in Kutch, Gujarat, for the cultivation of high-quality pomegranates. It will also set up a distillery facility in Kutch, the company Organisor has posted a multi-fold jump in revenue to Rs 854.82 crore for 2024-25 compared to revenue of Rs 2.54 crore in FY 2024. Net profit for FY 2025 surged to Rs 7.52 crore against Rs 5.31 lakh in FY company is engaged in the pharmaceutical business, including the marketing, trading, and distribution of a range of pharmaceutical products, such as antibiotics, anti-malarial drugs, and anti-allergic medications.